首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

市場調查報告書

商品編碼

1917774

全球臨床研究服務市場－2026-2031年預測

Global Clinical Research Services Market - Forecast from 2026 to 2031

出版日期: 2026年01月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球臨床研究服務市場預計將從 2025 年的 707.24 億美元成長到 2031 年的 1,095.51 億美元，複合年成長率為 7.57%。

由於臨床試驗需求激增，全球臨床研究服務市場正在擴張，迫使服務供應商擴大營運規模。研究活動外包提高了效率並縮短了藥物研發週期。快速發展的生物製藥和生物技術產業對專業臨床支援的需求龐大。多方面試驗中的國際合作正在推動創新治療方法的進步。

臨床研究服務涵蓋臨床試驗設計、實施和分析所需的各項服務，包括方案製定、病患招募、現場監查、資料管理、統計分析和監管申報。這些服務主要由合約研究組織 (CRO)、學術機構和專業公司提供，對於新藥、生物製藥和醫療設備的安全性、有效性和合規性評估至關重要。由於試驗複雜性的增加、跨境夥伴關係和技術整合，該市場正經歷穩定成長，這些因素共同促進了醫療創新並改善了患者的治療效果。

推動成長要素是對實證醫學日益成長的需求，實證醫學強調以嚴謹的科學檢驗來指導治療決策、減少實踐差異並最佳化資源配置。將臨床研究職能外包給合約研究組織 (CRO) 可以讓申辦方利用外部專業知識、實現擴充性、控制成本、加快患者招募並確保試驗按時合規地進行，同時專注於自身的核心競爭力。在研發投入、技術進步、慢性病發病率上升以及個人化醫療趨勢的推動下，生物製藥和生物技術產業的擴張正在推動對強大的臨床研究基礎設施的需求，以支持新型治療方法的開發。

市場細分反映了服務類型（例如臨床數據管理、品質保證、監控）、治療領域、最終用戶（製藥/生物技術公司、合約研究組織、學術/研究機構）和地理的多樣性。這種結構能夠滿足各個領域（例如腫瘤學、心臟病學和神經病學）內不同階段的試驗需求和專業需求。

從區域來看，北美佔據領先地位，這得益於其先進的醫療基礎設施、強大的製藥和生物技術生態系統、完善的法規結構以及眾多大型合約研究機構（CRO）和研究機構的集中。美國在臨床試驗和創新方面的大量投資鞏固了該地區的領先地位，而歐洲和亞太地區也仍然是重要的貢獻者。

主要供應商包括 IQVIA，提供涵蓋研究設計、現場管理、患者招募和數據分析的端到端服務；美國實驗室控股公司（LabCorp），提供臨床試驗測試、生物標記分析、中心檢查室支援和研究管理；Parexel International Corporation，提供包括研究通訊協定、數據處理、法規指導和招聘

總體而言，市場正穩步發展，並透過加強試驗開展、全球合作和外包專業知識，推動治療方法的突破，因為相關人員正在應對日益複雜的挑戰，以提供更安全、更有效的醫療干預措施。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The clinical research services market is expanding globally amid surging demand for clinical trials, prompting service providers to scale operations. Outsourcing of research activities is improving efficiency and shortening drug development timelines. The burgeoning biopharmaceutical and biotechnology sectors are generating substantial requirements for specialized clinical support. International collaborations on multifaceted trials are facilitating advancements in innovative therapies.

Clinical research services encompass a comprehensive suite of offerings essential for designing, executing, and analyzing clinical trials, including study protocol development, patient recruitment, site monitoring, data management, statistical analysis, and regulatory submissions. Delivered primarily by contract research organizations (CROs), academic institutions, and specialized firms, these services are indispensable for evaluating safety, efficacy, and compliance of new drugs, biologics, and devices. The market is experiencing steady growth, driven by escalating trial complexity, cross-border partnerships, and technological integration, all contributing to accelerated medical innovation and improved patient outcomes.

Key growth drivers include the mounting demand for evidence-based healthcare, which prioritizes rigorous scientific validation to guide treatments, reduce practice variability, and optimize resource allocation. Outsourcing clinical research functions to CROs enables sponsors to leverage external expertise, achieve scalability, contain costs, expedite recruitment, and maintain focus on core competencies while ensuring timely, compliant trial delivery. Expansion within biopharmaceutical and biotechnology industries-fueled by R&D investments, technological progress, rising chronic disease prevalence, and personalized medicine trends-heightens the need for robust clinical research infrastructure to support novel therapeutic development.

Segmentation reflects diversity by service type (e.g., clinical data management, quality assurance, monitoring), therapeutic area, end-user (pharmaceutical/biotech companies, CROs, academic/research institutions), and geography. This structure accommodates varied trial phases and specialized needs across oncology, cardiology, neurology, and other domains.

Geographically, North America commands the leading share, underpinned by advanced healthcare infrastructure, a dominant pharmaceutical/biotechnology ecosystem, supportive regulatory frameworks, and concentration of major CROs and research entities. Significant U.S. investment in trials and innovation reinforces regional primacy, though Europe and Asia-Pacific remain vital contributors.

Prominent providers include IQVIA, offering end-to-end services spanning study design, site management, patient recruitment, and data analytics. Laboratory Corporation of America Holdings (LabCorp) delivers clinical trial testing, biomarker analysis, central laboratory support, and trial management. PAREXEL International Corporation provides integrated solutions encompassing trial oversight, data handling, regulatory guidance, and recruitment. ICON plc supplies comprehensive capabilities from protocol design and site selection to data administration and submissions.

Overall, the market is advancing at a consistent pace, positioned to catalyze therapeutic breakthroughs through enhanced trial execution, global collaboration, and outsourced expertise, as stakeholders navigate increasing complexity to deliver safer, more effective medical interventions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Global Clinical Research Services Market Segmentation

By Service Type
Clinical Trial Management Services
Clinical Data Management Services
Regulatory Services
Clinical Monitoring Services
Quality Management Services
Bioanalytical Services
Others
By Therapeutic Area
Oncology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Diseases
Others
By End-User
Pharmaceutical And Biotechnology Companies
Contract Research Organizations (CROs)
Academic And Research Institutions
Others
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY SERVICE TYPE

5.1. Introduction
5.2. Clinical Trial Management Services
5.3. Clinical Data Management Services
5.4. Regulatory Services
5.5. Clinical Monitoring Services
5.6. Quality Management Services
5.7. Bioanalytical Services
5.8. Others

6. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY THERAPEUTIC AREA

6.1. Introduction
6.2. Oncology
6.3. Cardiovascular Diseases
6.4. Infectious Diseases
6.5. Neurology
6.6. Respiratory Diseases
6.7. Others

7. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY END-USER

7.1. Introduction
7.2. Pharmaceutical And Biotechnology Companies
7.3. Contract Research Organizations (Cros)
7.4. Academic And Research Institutions
7.5. Others

8. GLOBAL CLINICAL RESEARCH SERVICES MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others